Literature DB >> 12907471

Endocrine treatment of physiological gynaecomastia.

Hamed N Khan, R W Blamey.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12907471      PMCID： PMC1126712          DOI： 10.1136/bmj.327.7410.301

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Tamoxifen therapy for painful idiopathic gynecomastia.

Authors:  M T McDermott; F D Hofeldt; G S Kidd
Journal:  South Med J       Date:  1990-11       Impact factor: 0.954

2.  Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia.

Authors:  A C Ting; L W Chow; Y F Leung
Journal:  Am Surg       Date:  2000-01       Impact factor: 0.688

3.  Sonographic features of primary breast cancer in men.

Authors:  W T Yang; G J Whitman; E H Yuen; G M Tse; C B Stelling
Journal:  AJR Am J Roentgenol       Date:  2001-02       Impact factor: 3.959

4.  A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients.

Authors:  D J Jones; S D Holt; P Surtees; D J Davison; M J Coptcoat
Journal:  Ann R Coll Surg Engl       Date:  1990-09       Impact factor: 1.891

Review 5.  Gynecomastia.

Authors:  H E Carlson
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

Review 6.  Plastic surgery and the teenage patient.

Authors:  M H McGrath; S Mukerji
Journal:  J Pediatr Adolesc Gynecol       Date:  2000-08       Impact factor: 1.814

7.  Treatment of gynecomastia with tamoxifen: a double-blind crossover study.

Authors:  L N Parker; D R Gray; M K Lai; E R Levin
Journal:  Metabolism       Date:  1986-08       Impact factor: 8.694

8.  Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies.

Authors:  P V Plourde; H E Kulin; S J Santner
Journal:  Am J Dis Child       Date:  1983-11

9.  Idiopathic gynecomastia treated with tamoxifen: a preliminary report.

Authors:  T T Alagaratnam
Journal:  Clin Ther       Date:  1987       Impact factor: 3.393

10.  Adjuvant tamoxifen for male breast cancer (MBC).

Authors:  G Ribeiro; R Swindell
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640
  10 in total
  4 in total

1.  Tamoxifen is unproved for gynaecomastia.

Authors:  Julie C Doughty; Christopher R Wilson
Journal:  BMJ       Date:  2003-11-01

2.  Phenotype anchoring in zebrafish reveals a potential role for matrix metalloproteinases (MMPs) in tamoxifen's effects on skin epithelium.

Authors:  Sean M Bugel; Leah C Wehmas; Jane K La Du; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-18       Impact factor: 4.219

3.  [Breast cancer in men: about 6 cases].

Authors:  Kamilia Laabadi; Sofia Jayi; Fatimazohra Fdili Alaoui; Hakima Bouguern; Hikmat Chaara; My Abdelilah Melhouf; Karim Ibn Majdoub Hassani; Said Ait Laalim; Hicham Anoun; Imane Toughrai; Khalid Mazaz
Journal:  Pan Afr Med J       Date:  2013-10-28

Review 4.  Management of Adolescent Gynecomastia: An Update.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Mohamed Yassin
Journal:  Acta Biomed       Date:  2017-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.